Data / Federal rules / 2025-01840
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The Food and Drug Administration published this final rule in the Federal Register on January 27, 2025. It took effect on March 21, 2025.
SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.
What the agency says
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) is delayed until March 21, 2025.
Key facts
- Document number
- 2025-01840
- Type
- Final rule
- Action
- Final rule; delay of effective date
- Agency
- Health and Human Services Department; Food and Drug Administration
- Published
- January 27, 2025
- Takes effect
- March 21, 2025
- Dates
- The effective date for the final rule published December 26, 2024, (89 FR 105288), is delayed until March 21, 2025.
- Docket
- Docket No. FDA-2021-N-0862
- Regulation ID (RIN)
- 0910-AH62
- Code of Federal Regulations
- 21 CFR 201; 21 CFR 314
- Significant
- Yes, under Executive Order 12866
- Pages
- 2
Other documents from the Food and Drug Administration
Everything from the Food and Drug Administration · Published in January 2025
Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.